Spondyloarthritis & psoriatic arthritis

Plasma Proteomics Identifies Molecular Signatures and Biomarkers Associated With High Structural Damage in Ankylosing Spondylitis

Arthritis RheumatolPublished Proteomic biomarker study

Authors' conclusion

This study supports a dual-pathway model in which SAA2-marked systemic inflammation and ITGA2B-associated platelet-extracellular matrix remodeling appear partially dissociated yet remain biologically interconnected in AS.

Study context

Population
Patients with ankylosing spondylitis (AS) stratified by structural damage, and normal controlsdiscovery cohort
Participants
88 patients
Comparison
AS with high vs low structural damage vs normal controls
  • High structural damagen = 25
  • Low structural damagen = 31
  • Normal controlsn = 32reference
Outcome
Plasma protein signatures associated with structural damage severity in AS
Methodological detailsdiscovery and validation cohorts, prospective discovery cohort, independent validation cohort, age- and sex-adjusted differential expression analysis, weighted gene coexpression network analysis (WGCNA), integrated machine learning, ELISA validation
  • Discovery and validation cohorts
  • Prospective discovery cohort
  • Independent validation cohort
  • Age- and sex-adjusted differential expression analysis
  • WGCNA
  • Integrated machine learning
  • ELISA validation

Performance

As reported in the abstract

Plasma proteomic signatures of structural damage

Differentially expressed proteins, high structural damage vs normal controls

536

Combined model AUC, validation cohort

0.917

Individual biomarker AUCs (combined model significantly better; all Holm-adjusted P < 0.05)

0.732-0.819

Original publication

Plasma Proteomics Identifies Molecular Signatures and Biomarkers Associated With High Structural Damage in Ankylosing Spondylitis. Arthritis Rheumatol. Published 28 September 2026. doi:10.1002/art.70353

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.